307 related articles for article (PubMed ID: 20923854)
1. The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.
Visser M; Paulus WJ; Vermeulen MA; Richir MC; Davids M; Wisselink W; de Mol BA; van Leeuwen PA
Eur J Heart Fail; 2010 Dec; 12(12):1274-81. PubMed ID: 20923854
[TBL] [Abstract][Full Text] [Related]
2. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
[TBL] [Abstract][Full Text] [Related]
3. Effect of asymmetric dimethylarginine (ADMA) on heart failure development.
Liu X; Hou L; Xu D; Chen A; Yang L; Zhuang Y; Xu Y; Fassett JT; Chen Y
Nitric Oxide; 2016 Apr; 54():73-81. PubMed ID: 26923818
[TBL] [Abstract][Full Text] [Related]
4. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Selley ML
J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
Selley ML
J Neurosci Res; 2004 Jul; 77(1):90-3. PubMed ID: 15197741
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule.
Fliser D
Eur J Clin Invest; 2005 Feb; 35(2):71-9. PubMed ID: 15667575
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid inhibits cobalt chloride-induced apoptosis in PC12 cells: role of the dimethylarginine dimethylaminohydrolase/asymmetric dimethylarginine pathway.
Wang S; Hu CP; Jiang DJ; Peng J; Zhou Z; Yuan Q; Nie SD; Jiang JL; Li YJ; Huang KL
J Neurosci Res; 2009 Jun; 87(8):1938-46. PubMed ID: 19156866
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
[TBL] [Abstract][Full Text] [Related]
9. L-arginine regulates asymmetric dimethylarginine metabolism by inhibiting dimethylarginine dimethylaminohydrolase activity in hepatic (HepG2) cells.
Wang J; Sim AS; Wang XL; Wilcken DE
Cell Mol Life Sci; 2006 Dec; 63(23):2838-46. PubMed ID: 17075694
[TBL] [Abstract][Full Text] [Related]
10. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
Monsalve E; Oviedo PJ; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
Cardiovasc Res; 2007 Jan; 73(1):66-72. PubMed ID: 17097077
[TBL] [Abstract][Full Text] [Related]
11. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
Yamagishi S; Ueda S; Okuda S
Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.
Sharma S; Smith A; Kumar S; Aggarwal S; Rehmani I; Snead C; Harmon C; Fineman J; Fulton D; Catravas JD; Black SM
Vascul Pharmacol; 2010; 52(5-6):182-90. PubMed ID: 19962451
[TBL] [Abstract][Full Text] [Related]
13. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production.
Pope AJ; Karrupiah K; Kearns PN; Xia Y; Cardounel AJ
J Biol Chem; 2009 Dec; 284(51):35338-47. PubMed ID: 19820234
[TBL] [Abstract][Full Text] [Related]
14. Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease.
Wadham C; Mangoni AA
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):303-19. PubMed ID: 19331593
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase.
Achan V; Broadhead M; Malaki M; Whitley G; Leiper J; MacAllister R; Vallance P
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1455-9. PubMed ID: 12805079
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level.
Xiao HB; Jun-Fang ; Lu XY; Chen XJ; Chao-Tan ; Sun ZL
Eur J Pharmacol; 2009 Aug; 616(1-3):213-22. PubMed ID: 19549512
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric dimethylarginine and critical illness.
Brinkmann SJ; de Boer MC; Buijs N; van Leeuwen PA
Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):90-7. PubMed ID: 24281375
[TBL] [Abstract][Full Text] [Related]
18. The DDAH/ADMA/NOS pathway.
Tran CT; Leiper JM; Vallance P
Atheroscler Suppl; 2003 Dec; 4(4):33-40. PubMed ID: 14664901
[TBL] [Abstract][Full Text] [Related]
19. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
Palm F; Onozato ML; Luo Z; Wilcox CS
Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3227-45. PubMed ID: 17933965
[TBL] [Abstract][Full Text] [Related]
20. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase.
Achan V; Tran CT; Arrigoni F; Whitley GS; Leiper JM; Vallance P
Circ Res; 2002 Apr; 90(7):764-9. PubMed ID: 11964368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]